Page 12 - Sohini Das

Mixed Q1 results for top drug firms amid price erosion, tariff threat

Fresh launches boosted growth for players like Lupin, Torrent

Metropolis Healthcare unperturbed by Amazon's diagnostics segment foray

'Amazon's entry is through a partnership with Orange Health. It is more of a distribution through Amazon'

Tata Motors Q1 results: PAT down 30.5% on JLR tariff hit, lower volumes

The Ebitda margin was down 480 basis points (bps) year-on-year (Y-o-Y) to 9.2 per cent. Ebitda stands for earnings before interest, tax, depreciation, and amortisation

Confident about Biocon's response to US tariffs: Kiran Mazumdar-Shaw

We remain confident in our global footprint and are well positioned to respond once more details are available. , said Biocon Chairperson

Pharma Inc mulls offshore strategy as US tariff fears hit sentiment

Despite current exemptions, Indian pharma firms are preparing for potential US tariffs through offshore units, EU market focus, and sourcing diversification

Bajaj Auto cuts electric 2-W production by half amid rare earth shortage

Executive Director Rakesh Sharma told reporters in post-earnings call that they have already cut their e-2W production by as much as 50 per cent in July

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower

Swedish car giant Volvo Cars India expects modest sales growth this year

Volvo Cars India anticipates flat sales growth in 2025 due to a combination of macroeconomic challenges and forex fluctuations but remains optimistic about 2026 and 2027

Tata Motors to raise €1 bn via equity, stake sale to fund Iveco deal

Iveco gets India entry while Tata gains Latin American access

Daewoo deal helped us understand how to compete: Tata Motors exec

TaMo plans to tap into premium customer segments and cohorts of Iveco which complements its current positioning

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social

M&M Q1 PAT rises 24% to ₹4,083 crore on strong auto volume growth

Auto volumes rise 17 per cent, SUV market share improves 570 bps to 27.3 per cent, while farm and services also report healthy margins and profits in Q1FY26

Mahindra EV biz posts ₹111 crore Q1 EBITDA, awaits PLI nod for XUV9e

Strong demand for electric SUVs boosts Mahindra's EV business to Rs 111 crore EBITDA in Q1FY26; company awaits PLI certificate and ramps up production gradually

How Wockhardt's bet on multi-drug resistant infections is paying off

In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed

US CDMO business seeing softening, says Piramal Pharma Chairperson

US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains long-term growth targets

Shailesh Jejurikar becomes first Indian to lead 187-year-old P&G

Chief operating officer of consumer goods conglomerate will succeed Jon Moeller

Battle for ownership brews at Sona BLW after Sunjay Kapur's death

Firm proceeds with AGM despite objections from Kapur's mother

Govt to closely monitor price hikes of drugs outside essential list

The NPPA will ensure drug companies do not exceed the 10% annual price increase limit on non-essential medicines

India-UK trade deal: Smooth road ahead as luxury cars set to get cheaper

Under the FTA, tariffs on automotive imports will come down by 50 per cent over 10 years (out of quota)

India-UK trade deal: Med device firms cautious about country of origin

The UK-India Free Trade Agreement is expected to boost trade in pharmaceuticals and medical devices, though industry players remain cautious about the impact of country of origin rules